Daily requirements
- For the ‘average’ 70 Kg man
- Total body water is 42 L (~60% of body weight)
- 28 L is in the intracellular and 14 L in the extracellular compartments
- The plasma volume is 3 L
- The extravascular volume is 11 L
- Total body Na+ is 4200 mmol (50% in ECF)
- Total body K+ is 3500 mmol (only about 50-60
mmol in ECF)
- Normal osmolality of ECF is 280 –295 mosmol/kg
Fluid replacement
When calculating fluid replacement for a patients need to consider:
Maintenance requirements
- Daily maintenance fluid requirements vary between individuals.
- 70 Kg male = 2.5 - 3.0L water, 120 – 140 mmol sodium and 70 mmol potassium
- 40 Kg woman = 2.0L water,70 – 90 mmol sodium and 40 mmol potassium
- Daily maintenance fluid requirements for children
- 0-10 kg is 100 ml/kg
- 10-20 kg is 1000 ml + 50 ml/kg for each kg > 10
- >20 kg is 1500 ml + 25 ml/kg for each kg > 20
Replacement of losses
- Pre-operative or pre-admission
- Ongoing losses
- Nasogastric aspirate
- Vomit, diarrhoea
- Stoma, drains, fistula etc
- Most ‘surgical ‘ ongoing losses are rich in sodium and should be replaced with 0.9% saline
Insensible losses
- Faeces approximately 100 ml/ day
- Lungs approximately 400 ml/ day
- Skin approximately 600 ml/ day
Composition of crystalloids
|
Hartmann’s Solution
|
Normal Saline
|
Dextrose Saline |
| Sodium (mmol/l) |
131 |
150 |
30 |
| Chloride (mmol/l) |
111 |
150 |
30 |
| Potassium (mmol/l) |
5 |
Nil |
Nil |
| Bicarbonate (mmol/l) |
29 |
Nil |
Nil |
| Calcium (mmol/l) |
2 |
Nil |
Nil |
- 3L of Dextrose saline is not equivalent to 2L 5% Dextrose and 1L Normal saline
- 3L Dextrose Saline = 3L water and 90 mmol sodium
- 2L 5% Dextrose saline + 1L Normal saline = 3L water and 154 mmol sodium
Composition of colloids
|
Volume effect (%)
|
Average MW (kDa)
|
Circulatory half life
|
| Gelatins (Haemaccel) |
80 |
35 |
2-3 hours |
| 4% Albumin |
100 |
69 |
15 days |
| Dextran 70 |
120 |
41 |
2-12 hours |
| 6% Hydroxyethyl Starch |
100 |
70 |
17 days |
- Monodispersed = All molecules of similar molecular weight
- Polydispersed = Molecules have spread of molecular weights
Albumin
- Monodispersed
- Expensive
- Long half life
- Accounts for 60-80% of normal plasma oncotic pressure
- No adverse effect on coagulation
Dextrans
- Polysaccharides
- Polydispersed with MW 10-90 kDa
- Reduces plasma viscosity
- Reduces platelet aggregation
- 1-5% develop anaphylaxis
Gelatins
- Polypeptides
- Polydispersed with MW ~35 kDa
- Rapidly lost from vascular space
- Hydroxyethyl starch
- Synthetic polysaccharide polymers derived from amylopectin
- Polydispersed with MW 50-450 kDa
- Large molecules engulfed by reticuloendothelial system
- Associated with bleeding diathesis
Assessment of adequacy of resuscitation
- Clinical history and observations – Pulse, blood pressure, skin turgor
- Urine output – oliguria < 0.5 ml/kg/hr
- CVP or pulmonary capillary wedge pressure
- Response of urine output or CVP to fluid challenge
- A fluid challenge should be regarded as a 200-250 ml bolus of colloid
- This should be administered as quickly as possible
- A response in the CVP or urine output should be seen within minutes
- The size and duration of the CVP response rather the actual values recorded is more important
GIFTASUP Recommendations (2008)
Recommendation 1
- Because of the risk of inducing hyperchloraemic acidosis in
routine practice, when crystalloid resuscitation or replacement is
indicated, balanced salt solutions (e.g. Ringer’s lactate/acetate or
Hartmann’s solution) should replace 0.9% saline, except in cases of
hypochloraemia
Recommendation 2
- Solutions such as 4% / 0.18% dextrose/saline and 5% dextrose are
important sources of free water for maintenance, but should be used
with caution as excessive amounts may cause dangerous hyponatraemia,
especially in children and the elderly. These solutions are not
appropriate for resuscitation or replacement therapy except in
conditions of significant free water deficit (e.g. diabetes insipidus)
Recommendation 3
- To meet maintenance requirements, adult patients should receive
sodium 50-100 mmol/day, potassium 40-80 mmol/day in 1.5-2.5 litres of
water by the oral, enteral or parenteral route (or a combination of
routes). Additional amounts should only be given to correct deficit or
continuing losses. Careful monitoring should be undertaken using
clinical examination, fluid balance charts, and regular weighing when
possible
Preoperative fluid management
Recommendation 4
- In patients without disorders of gastric emptying undergoing
elective surgery clear non-particulate oral fluids should not be
withheld for more than two hours prior to the induction of anaesthesia
Recommendation 5
- In the absence of disorders of gastric emptying or diabetes,
preoperative administration of carbohydrate rich beverages 2-3 h
before induction of anaesthesia may improve patient well being and
facilitate recovery from surgery. It should be considered in the
routine preoperative preparation for elective surgery
Recommendation 6
- Routine use of preoperative mechanical bowel preparation is not
beneficial and may complicate intra and postoperative management of
fluid and electrolyte balance. Its use should therefore be avoided
whenever possible
Recommendation 7
- Where mechanical bowel preparation is used, fluid and electrolyte
derangements commonly occur and should be corrected by simultaneous
intravenous fluid therapy with Hartmann’s or Ringer-Lactate/acetate
type solutions
Recommendation 8
- Excessive losses from gastric aspiration or vomiting should be
treated preoperatively with an appropriate crystalloid solution which
includes an appropriate potassium supplement. Hypochloraemia is an
indication for the use of 0.9% saline, with sufficient additions of
potassium and care not to produce sodium overload. Losses from
diarrhoea, ileostomy, small bowel fistula, ileus or obstruction should
be replaced volume for volume with Hartmann’s or
Ringer-Lactate/acetate type solutions. “Saline depletion,” for example
due to excessive diuretic exposure, is best managed with a balanced
electrolyte solution such as Hartmann's
Recommendation 9
- In high risk surgical patients, preoperative treatment with
intravenous fluid and inotropes should be aimed at achieving
predetermined goals for cardiac output and oxygen delivery as this may
improve survival
Recommendation 10
- Although currently logistically difficult in many centres,
preoperative or operative hypovolaemia should be diagnosed by
flow-based measurements wherever possible. The clinical context should
also be taken into account as this will provide an important
indication of whether hypovolaemia is possible or likely. When direct
flow measurements are not possible, hypovolaemia will be diagnosed
clinically on the basis of pulse, peripheral perfusion and capillary
refill, venous pressure and Glasgow Coma Scale together with acid-base
and lactate measurements. A low urine output can be misleading and
needs to be interpreted in the context of the patient’s cardiovascular
parameters above
Recommendation 11
- Hypovolaemia due predominantly to blood loss should be treated
with either a balanced crystalloid solution or a suitable colloid
until packed red cells are available. Hypovolaemia due to severe
inflammation such as infection, peritonitis, pancreatitis or burns
should be treated with either a suitable colloid or a balanced
crystalloid. In either clinical scenario, care must be taken to
administer sufficient balanced crystalloid and colloid to normalise
haemodynamic parameters and minimise overload. The ability of
critically ill patients to excrete excess sodium and water is
compromised, placing them at risk of severe interstitial oedema. The
administration of large volumes of colloid without sufficient free
water (e.g. 5% dextrose) may precipitate a hyperoncotic state
Recommendation 12
- When the diagnosis of hypovolaemia is in doubt and the central
venous pressure is not raised, the response to a bolus infusion of 200
ml of a suitable colloid or crystalloid should be tested. The response
should be assessed using the patient’s cardiac output and stroke
volume measured by flow-based technology if available. Alternatively,
the clinical response may be monitored by measurement/estimation of
the pulse, capillary refill, CVP and blood pressure before and 15
minutes after receiving the infusion. This procedure should be
repeated until there is no further increase in stroke volume and
improvement in the clinical parameters
Intraoperative fluid management
Recommendation 13
- In patients undergoing some forms of orthopaedic and abdominal
surgery, intraoperative treatment with intravenous fluid to achieve an
optimal value of stroke volume should be used where possible as this
may reduce postoperative complication rates and duration of hospital
stay
Recommendation 14
- Patients undergoing non-elective major abdominal or orthopaedic
surgery should receive intravenous fluid to achieve an optimal value
of stroke volume during and for the first eight hours after surgery.
This may be supplemented by a low dose dopexamine infusion
Postoperative fluid, and nutritional management.
Recommendation 15
- Details of fluids administered must be clearly recorded and easily
accessible
Recommendation 16
- When patients leave theatre for the ward, HDU or ICU their volume
status should be assessed. The volume and type of fluids given
perioperatively should be reviewed and compared with fluid losses in
theatre including urine and insensible losses
Recommendation 17
- In patients who are euvolaemic and haemodynamically stable a
return to oral fluid administration should be achieved as soon as
possible
Recommendation 18
- In patients requiring continuing i.v. maintenance fluids, these
should be sodium poor and of low enough volume until the patient has
returned their sodium and fluid balance over the perioperative period
to zero. When this has been achieved the i.v. fluid volume and content
should be those required for daily maintenance and replacement of any
on-going additional losses
Recommendation 19
- The haemodynamic and fluid status of those patients who fail to
excrete their perioperative sodium load, and especially whose urine
sodium concentration is <20mmol/L, should be reviewed
Recommendation 20
- In high risk patients undergoing major abdominal surgery,
postoperative treatment with intravenous fluid and low dose dopexamine
should be considered, in order to achieve a predetermined value for
systemic oxygen delivery, as this may reduce postoperative
complication rates and duration of hospital stay
Recommendation 21
- In patients who are oedematous, hypovolaemia if present must be
treated, followed by a gradual persistent negative sodium and water
balance based on urine sodium concentration or excretion. Plasma
potassium concentration should be monitored and where necessary
potassium intake adjusted
Recommendation 22
- Nutritionally depleted patients need cautious refeeding orally,
enterally or parenterally, with feeds supplemented in potassium,
phosphate and thiamine. Generally, and particularly if oedema is
present, these feeds should be reduced in water and sodium. Though
refeeding syndrome is a risk, improved nutrition will help to restore
normal partitioning of sodium, potassium and water between intra and
extra-cellular spaces
Recommendation 23
- Surgical patients should be nutritionally screened, and NICE
guidelines for perioperative nutritional support adhered to. Care
should be taken to mitigate risks of the refeeding syndrome
Fluid management in acute kidney injury
Recommendation 24
- Based on current evidence, higher molecular weight hydroxyethyl
starch should be avoided in patients with severe sepsis due to an
increased risk of AKI
Recommendation 25
- Higher molecular weight hydroxyethyl starch should be avoided in
brain-dead kidney donors due to reports of osmotic-nephrosis-like
lesions
Recommendation 26
- Balanced electrolyte solutions containing potassium can be used
cautiously in patients with AKI closely monitored on HDU or ICU in
preference to 0.9% saline. If free water is required 5% dextrose or
dextrose saline should be used. Patients developing hyperkalaemia or
progressive AKI should be switched to non potassium containing
crystalloid solutions such as 0.45% saline or 4%/0.18 dextrose/saline
Ringer’s lactate versus 0.9% saline for patients with AKI
Recommendation 27
- In patients with AKI fluid balance must be closely observed and
fluid overload avoided. In patients who show signs of refractory fluid
overload, renal replacement therapy should be considered early to
mobilize interstitial oedema and correct extracellular electrolyte and
acid base abnormalities
Recommendation 28
- Patients at risk of developing AKI secondary to rhabdomyolysis
must receive aggressive fluid resuscitation with an isotonic
crystalloid solution to correct hypovolaemia. There is insufficient
evidence to recommend the specific composition of the crystalloid.
Bibliography
Choi P T-L, Yip G, Quinonez
L G, Cook D J. Crystalloids
vs. colloids in fluid resuscitation: a systematic review.
Crit Care Med 1999; 27:
200-210.
Jung B, Pahlman L, Nystrom PO et al. Multicentre randomized
clinical trial of mechanical bowel preparation in elective colonic
resection. Br J Surg 2007; 94: 689-695.
Lobo D N, Bostock KA, Neal KR et al. Effect of salt and water
balance on recovery of gastrointestinal function after elective colonic
resection: a randomised controlled trial. Lancet 2002; 359:
1812-1818.
Noblett S E, Snowden C P, Shenton B K et al. Randomized
clinical trial assessing the effect of doppler-optimized fluid
management on outcome after elective colorectal resection. Br J Surg
2006; 93: 1069-1076.
Schierhout G, Roberts I, Alderson
P. Colloids versus crystalloids for fluid resuscitation in
critically ill patients (Cochrane Review). In: The Cochrane library, Issue
1, 1999. Oxford.
Traylor R J, Pearl R G. Crystalloid
versus colloid versus colloid: All colloids are nor equal. Anaesth Analg 1996; 83;
209-212. |